Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice

Overview of attention for article published in Arthritis Research & Therapy, December 2014

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,008 followers.

Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice http://t.co/e4zMOeVXq7

Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice http://t.co/e4zMOeVXq7

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.